(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.16%) $82.50
(1.38%) $2.06
(-0.48%) $2 346.40
(-0.99%) $27.39
(-0.07%) $960.80
(0.12%) $0.934
(0.21%) $11.01
(0.07%) $0.797
(0.01%) $93.31
Live Chart Being Loaded With Signals
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally...
Stats | |
---|---|
今日成交量 | 160 800 |
平均成交量 | 31.55M |
市值 | 31.40B |
EPS | CNY0 ( 2024-04-25 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 22.17 |
ATR14 | CNY0.0210 (0.11%) |
音量 相关性
Pharmaron Beijing Co., 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Pharmaron Beijing Co., 相关性 - 货币/商品
Pharmaron Beijing Co., 财务报表
Annual | 2023 |
营收: | CNY11.46B |
毛利润: | CNY3.80B (33.18 %) |
EPS: | CNY0.900 |
FY | 2023 |
营收: | CNY11.46B |
毛利润: | CNY3.80B (33.18 %) |
EPS: | CNY0.900 |
FY | 2022 |
营收: | CNY10.27B |
毛利润: | CNY3.77B (36.71 %) |
EPS: | CNY0.780 |
FY | 2021 |
营收: | CNY7.44B |
毛利润: | CNY2.68B (35.99 %) |
EPS: | CNY2.05 |
Financial Reports:
No articles found.
Pharmaron Beijing Co.,
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。